Table 2.

Comparison of UCSF Clinical Genetics engagement and germline testing for patients with PDAC before and after implementation of GTS

Clinical efficacy metric	Before GTS	After GTS	p value a
Total patients with PDAC seen at UCSF	n = 432	n = 223
Referred to Clinical Genetics/GTS	137/432 (32%)	147/223 (66%)	<.001
Referral appointment attended	88/137 (64%)	143/147 (97%)	<.001
Testing completed at UCSF	82/137 (60%)	135/147 (92%)	<.001
Pathogenic variant detected	16/82 (20%)	44/135 (33%)	.04
Overall germline testing confirmed	82/432 (19%)	158/223 (71%)	<.001

Abbreviations: PDAC, pancreatic ductal adenocarcinoma; GTS, genetic testing station; UCSF, University of California San Francisco.

^a Two‐tailed chi‐square.